(IN BRIEF) Montagu and Astorg have welcomed LGT Capital Partners as a new minority shareholder in Nemera, a global leader in drug delivery devices. Montagu and Astorg will remain majority shareholders while partnering with LGT CP to drive Nemera’s next … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, United Kingdom
Tagged Andreas Hellmann, Astorg, auto-injectors, biotech solutions, drug delivery devices, Global Expansion, Héloïse Pujolle, inhalers, innovation in healthcare, LGT Capital Partners, manufacturing capacity, Montagu, Nemera, Nicolas Marien, pharmaceutical manufacturing, private equity healthcare investments, proprietary product portfolio
(IN BRIEF) SCHOTT Pharma has begun construction on a new production facility for ready-to-use (RTU) cartridges at its Lukácsháza site in Hungary. The investment of over 100 million euros will expand the company’s manufacturing capacity to meet increasing demand for … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Hungary, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics, Diabetes, Eva Szabó, expansion, GLP-1 drugs, high-value solutions, hormone therapies, Hungary, insulin, investment, Lukácsháza, manufacturing capacity, Ministry of Foreign Affairs and Trade, Obesity, partnership, pharmaceutical industry, pharmaceutical packaging, ready-to-use cartridges, SCHOTT Pharma, sterile cartridges, sustainability, sustainable development
(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support the development of innovative treatments for obstructive sleep apnea (OSA). This funding, backed by the InvestEU Life Sciences programme, will … Read the full press release
Posted in Banks, Belgium, European Union, Financial, Healthcare, Pharma & Biotech
Tagged Belgium, commercialization, EIB, equity offering, Europe, European Investment Bank, financing, Genio system, hypoglossal neurostimulation therapy, INNOVATION, InvestEU, InvestEU Life Sciences programme, life sciences, manufacturing capacity, medtech, Nyxoah, obstructive sleep apnea, Olivier Taelman, OSA, production capacity, research and development, Robert de Groot, technological innovation, US, venture-debt financing
(PRESS RELEASE) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), a global enterprise with core competencies in the life science fields of healthcare and nutrition and and one of the largest pharmaceutical companies in the world, has announced … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Spain
Tagged analytical development, Asklepios BioPharmaceutical, Bayer, Certified Good Manufacturing Practices (cGMP), commercial manufacturing, contract development and manufacturing organization (CDMO), European Medicines Agency (EMA), gene therapies, Javier García, Jimmy Vanhove, manufacturing capacity, quality control labs, recombinant adeno-associated virus (rAAV), science and technology (MSAT), single-use bioreactors, Spanish Agency for Medicines and Medical Devices (AEMPS), Viralgen Vector Core
(PRESS RELEASE) LONDON, 9-Feb-2021 — /EuropaWire/ — COVID-19 taught us numerous things when it comes to manufacturing. Throughout 2020, we saw countless industries and companies alike struggling to source materials, complete production, and get their product to the end user. … Read the full press release
Posted in Automotive, Business, Electronics & Machinery, Industrial, International Trade, Metals and Minerals, News, Transportation & Logistics, United Kingdom
Tagged advanced manufacturing, digital manufacturing marketplace, digital manufacturing platform, digital online marketplace, digital supply network, industrial component shortage, Manufacturing, manufacturing capacity, metal additive manufacturing, source materials, supply chain, supply chain stability, supply chain transparency
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?